The vaccine produced "a good immune response," and trial participants suffered no serious adverse events, investigators reported. The second phase of the trial is ongoing and a third phase will launch this month.
from Bizjournals.com Feed (2019-07-18 12:47:42) https://www.bizjournals.com/atlanta/news/2020/07/15/emory-researchers-covid-19-vaccine-trial-good.html?ana=brss_609
Mold Remediation Pros
No comments:
Post a Comment